Pre-IND and Distribution Strategies - Ensuring Efficient Clinical Studies

Navigating the complexities of early-phase clinical trials requires strategic foresight and regulatory expertise. 

Hear from our industry experts, Sharlett Burgess and Zach Rupert, as they share invaluable insights on:

• Pre-IND Strategy & Regulatory Considerations – How proactive planning can reduce First Patient-In (FPI) timelines by 6-8 weeks and streamline the IND submission process.
• Leveraging a Canadian CDMO – Understanding the benefits of importing, labeling, and packaging clinical trial materials in Canada to enable immediate shipment post-IND approval.
• Global Depot & Distribution Strategies – Overcoming supply chain complexities with a tailored approach for different regulatory environments worldwide.
• Risk Mitigation & Compliance – Addressing potential challenges in Pre-IND packaging, import/export logistics, and evolving global trade & tariff regulations.

This webinar will help you enhance your clinical supply strategy, reduce regulatory bottlenecks, and ensure seamless distribution of investigational medicinal products.

Subject Matter Experts

Sharlett Burgess

Senior Director, Quality Operations and Global Strategy

Zach Rupert

Director, Global Specialty Logistics